Kestrel Capital brings expertise and a strong track record of delivering superior returns by helping management teams deliver on global opportunities. We have completed on investments across a broad array of investment types, business life cycle, industries based in Australia and New Zealand expanding internationally.

SomnoMed

Development, manufacturing and marketing of innovative dental and medical products, with a focus on sleep-disordered breathing. ASX listed.

 

Period: Current

Need Met: Recapitalise business and fund growth. Listed Equity.

What Kestrel Achieved: Assisted management as non-board, top-10 shareholder, with industry and market knowledge.

Exit: Ongoing investor. Current IRR 25+%

© 2014 Kestrel Capital Pty Limited

ABN 68 061 515 062
AFSL 227065